Company / Goodwill
Barinthus Biotherapeutics plc. Goodwill History
FY2021-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Goodwill
$12.2M
FY2023
5-year range
$12.2M / $12.6M
FY2021-FY2023
Trend
-3.3%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Goodwill remained relatively stable over the past 3 years, with values between $12M and $13M.
Based on SEC 10-K filings.
$12M in FY2023.
Declined from $13M to $12M over the past 2 years.
Goodwill over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, goodwill decreased 3.3% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.06 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | GoodwillValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $12.2M | -3.3% |
| FY2022 | $12.6M | +0.0% |
| FY2021 | $12.6M | - |
As of FY2023 · SEC 10-K · Updated Jun 24, 2026